CommercialBilling CodesMedium impact
11.03.11r, Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)
Independence Blue Cross·Gastroenterology, General Surgery·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued GERD treatment policy 11.03.11r effective 01/01/2026 with CPT code updates adding six new experimental/investigational codes (1013T-1018T) for GERD procedures. No changes to coverage criteria for surgical fundoplication or magnetic esophageal ring implantation; the new codes are not covered pending evidence review.
Action Required
By 12/31/2025: Billing team must update billing system to recognize the six new CPT codes (1013T, 1014T, 1015T, 1016T, 1017T, 1018T) as experimental/investigational and route to denial for Independence Blue Cross commercial plans. Verify that existing GERD procedure codes (43280, 43284, 43285, 43325, 43327, 43328) remain marked as covered when medical necessity criteria are met (documented failed medical management or comorbidities for fundoplication; documented failed PPI therapy, proven GERD, adequate peristalsis, and absence of contraindications for magnetic ring). Educate providers that any claims submitted with the new codes will be denied as non-covered services. Update internal policy reference materials to reflect reissue date of 06/10/2026 for audit trail.